Claros Diagnostics Raises $4 Million

Claros Diagnostics Inc., a Woburn, Mass.-based developer of handheld urological cancer diagnostic testing systems for point-of-care use, has raised $4 million in second-round funding, according to a regulatory filing. Shareholders include Oxford Bioscience Partners, Bioventures Investors, Accelerated Technologies Partners and Commons Capital. www.clarosdx.com

Leave a Reply

PEHUB Community

Join the 12505 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget